Publications


Radiopaque Resorbable Inferior Vena Cava Filter Infused with Gold Nanoparticles;
Tian, L, Lee, P, Singhana, B, Chen, A, Qiao, Y, Lu, L, Martinez, JO, Tasciotti, E, Melancon, A, Huang, S, Eggers, M & Melancon, MP 2017, Scientific Reports, vol 7, no. 1, 2147. DOI:

Superior Petrosal Vein Sacrifice During Microvascular Decompression: Perioperative Complication Rates and Comparison with Venous Preservation;
Liebelt, BD, Barber, SM, Desai, VR, Harper, R, Zhang, J, Parrish, R, Baskin, DS, Trask, T & Britz, GW 2017, World Neurosurgery, vol 104, pp. 788-794. DOI:

Developing Spindlin1 small-molecule inhibitors by using protein microarrays;
Bae, N, Viviano, M, Su, X, Lv, J, Cheng, D, Sagum, C, Castellano, S, Bai, X, Johnson, C, Khalil, MI, Shen, J, Chen, K, Li, H, Sbardella, G & Bedford, MT 2017, Nature Chemical Biology, vol 13, no. 7, pp. 750-756. DOI:

Videoexoscopic real-time intraoperative navigation for spinal neurosurgery: a novel co-adaptation of two existing technology platforms, technical note;
Huang, M, Barber, SM, Steele, WJ, Boghani, Z, Desai, VR, Britz, GW, West, GA, Trask, TW & Holman, PJ 2017, Journal of Robotic Surgery, pp. 1-5. DOI:

Targeting Translational Successes through CANSORT-SCI: Using Pet Dogs to Identify Effective Treatments for Spinal Cord Injury;
Moore, SA, Granger, N, Olby, NJ, Spitzbarth, I, Jeffery, ND, Tipold, A, Nout-Lomas, YS, Da Costa, RC, Stein, VM, Noble-Haeusslein, LJ, Blight, AR, Grossman, RG, Basso, DM & Levine, JM 2017, Journal of Neurotrauma, vol 34, no. 12, pp. 2007-2018. DOI:

Prevalence of in-hospital nonsteroidal antiinflammatory drug exposure in patients with a primary diagnosis of heart failure;
Alvarez, PA, Putney, D, Ogunti, R, Puppala, M, Ganduglia, C, Torre-Amione, G, Schutt, R, Wong, STC & Estep, JD 2017, Cardiovascular Therapeutics, vol 35, no. 3. DOI:

Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure—does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS);
Cleland, JGF, Teerlink, JR, Davison, BA, Shoaib, A, Metra, M, Senger, S, Milo, O, Cotter, G, Bourge, RC, Parker, JD, Jondeau, G, Krum, H, OConnor, CM, Torre-Amione, G, van Veldhuisen, DJ, McMurray, JJV & for the VERITAS Investigators 2017, European Journal of Heart Failure, vol 19, no. 6, pp. 739-747. DOI:

Nanoantibiotics: A new paradigm for the treatment of surgical infection;
Moure, JSF, Evangelopoulos, M, Colvill, K, Van Eps, JL & Tasciotti, E 2017, Nanomedicine, vol 12, no. 11, pp. 1319-1334. DOI:

Targeting autocrine CCL5-CCR5 axis reprograms immunosuppressive myeloid cells and reinvigorates antitumor immunity;
Ban, Y, Mai, J, Li, X, Mitchell-Flack, M, Zhang, T, Zhang, L, Chouchane, L, Ferrari, M, Shen, H & Ma, X 2017, Cancer Research, vol 77, no. 11, pp. 2857-2868. DOI:

Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester;
Gillard, BK, Bassett, GR, Gotto, AM, Rosales, C & Pownall, HJ 2017, Journal of Biological Chemistry, vol 292, no. 21, pp. 8864-8873. DOI: